IFRX

KGKay

BMGL, BNRG, UOKA, BURU, XLO, IFRX, RXT,  Pick your poison. I didn’t feel research the charts but I liked the setups. I use to trade Options for a long time. Very skilled in TA, However like I said above. I quick examined the charts. Personally I like BNRG. It’s my favorite. So I will go with that. We also have economic data today. IWM can also help you decide on your move. 

Ambitious-Nature7954

$IFRX about to pop. Book value at $2.12/share. $24M cash and only $1.17M debt. Only $1.70 now.

sad_and_disappointed

Not sure about advance knowledge but I saw IFRX move AH on **Zendoo** (someone who lives in snowy climes shares a free scanner. It calls out stocks that are running, in real time. You may want to check it out on youtube tomorrow, his power is out today due to inclement weather). Oftentimes, tickers that run over 50% AH seem to have continuation, at least through the morning so I took a chance and held some overnight.

Waxy311

According to yahoo finance: “Shares of InflaRx (NASDAQ: IFRX) were up 48% an hour after the market opened on Wednesday on news the company's COVID-19 therapy was receiving an Emergency Use Authorization (EUA) from the Food and Drug Administration (FDA). The healthcare stock jumped to a 52-week high of $7.25 a share in early trading after the FDA approved an EUA for Gohibic (vilobelimab), a monoclonal anti-human complement factor C5a antibody, to treat hospitalized COVID-19 patients within 48 hours of receiving oxygen through a ventilator or through a heart-lung machine. The EUA is based on the company's successful phase 3 study of the drug on 369 hospitalized patients that showed a 23.9% reduction in the mortality rate compared with placebo.” Seems like something you would need to have been tracking and waiting for the news to hit this morning and gotten in at the bell. This could be a good short term gamble/investment to see how high it goes in the next few months and keep an eye out on the news of its effectiveness. Could have the Moderna effect for a while, before it stabilizes or market corrects. Probably will correct and drop a bit tomorrow but still has potential over next few months. I have $10 saved for down payment of house, had I put it into Apple or meta 3 months ago that would have been up about 50%, or so I gamble it with something like this? Def don’t wanna lose that money so what’s the smart play, I’d say not to put anything in I can’t afford to lose. Not financially advisable advice. Not a financial advisor just an ape looking to double my savings to get a house faster.

VisualMod

I am a bot. You submitted a picture of a banned ticker, IFRX. The market cap of IFRX is **91,642,710** This check will fire if you included unnecessary pictures that have bad keywords/phrases. Repost with the useless pictures omitted if you did that.

TheHippoScientist

IFRX

Stimp421

IFRX

ColdMeeting2595

Inflarx IFRX wake up people Approval for China can come at any time. The Olympic Games will speed it up. The Chinese vaccine does not help against omicron. Here is a huge market for 10 million or more drugs to Indonesia and India. 10 million times very conservative 1000 euros royalties. we are about to re-evaluate

ColdMeeting2595

Inflarex IFRX Germany course € 3.80 Biopharma Further decision studies will be completed in the 1st half of 2022 including: Vilobelimab is not a Covid drug !!! It combats sepsis caused by Covid, and sepsis existed before Covid ... and will last long after Covid. Sepsis is one of the most common and cost-intensive diseases in the inpatient area. [1] The World Health Organization (WHO) declared the disease to be one of the leading priorities in the health systems of the member states in 2017 in order to improve the prevention, diagnosis, treatment, recording and follow-up of sepsis patients. Here's a billion dollar market if not so billiards. And Inflarex is on the verge of being the best drug with the fewest side effects. Just a few days!

ColdMeeting2595

Inflarex IFRX Germany course € 3.80 Biopharma Further decision studies will be completed in the 1st half of 2022 including: Vilobelimab is not a Covid drug !!! It combats sepsis caused by Covid, and sepsis existed before Covid ... and will last long after Covid. Sepsis is one of the most common and cost-intensive diseases in the inpatient area. [1] The World Health Organization (WHO) declared the disease to be one of the leading priorities in the health systems of the member states in 2017 in order to improve the prevention, diagnosis, treatment, recording and follow-up of sepsis patients. Here's a billion dollar market if not so billiards. And Inflarex is on the verge of being the best drug with the fewest side effects. Just a few days!

ColdMeeting2595

IFRX let's play inflaex NL0012661870. Only 27 million shares outstanding. Over 130 million in the bank. New Covid drug is about to be approved. Just received another $ 50 million in funding from the German government. Look at the diagram and come to Stocktwits. New target price of $ 16

ColdMeeting2595

IFRX I would add Inflarax to where the final study of your Covid drug release is due in the coming weeks. The German federal government is already ready to prepare a quick approval, the reaction has already paid 25 million dollars to inflarax to set up production at the same time. Currently below 4 dollars could quickly go to 20 dollars

ColdMeeting2595

IFRX Top Biopharma Newcomer BiG Newspipeline 2022

ColdMeeting2595

Go to Inflarax IFRX Simply put, Inflarax has many studies in the final phase where you alone have the potential to increase the price by 400% all at once: Corona, cancer, pneumonia. A billion dollar market.

ColdMeeting2595

Inflarax Up Potential 400% IFRX Deutschland BIOPHARMA Top Newspipeline 2022 4 Dollar Finish 20 Dollar possible

ColdMeeting2595

Inflarax Up Potential 400% IFRX Germany BIOPHARMA Top Newspipeline 2022 4 Dollar Finish 20 Dollar possible

ColdMeeting2595

IFRX Germany BIOPHARMA Newcomer BiG Pipeline

ColdMeeting2595

Inflarax Top Pipeline Germany BIOPHARMA 4 Dollar IFRX

ColdMeeting2595

IFRX 

ColdMeeting2595

IFRX Germany Biopharma Simply put, Inflarax has a lot of studies in the final phase, where one alone has the potential to increase the price by 400% at once: Corona, cancer, pneumonia. A billion market.

ColdMeeting2595

IFRX Germany Biopharma Simply put, Inflarax has a lot of studies in the final phase, where one alone has the potential to increase the price by 400% at once: Corona, cancer, pneumonia. A billion market.

ColdMeeting2595

IFRX Simply put, Inflarax has a lot of studies in the final phase, where one alone has the potential to increase the price by 400% at once: Corona, cancer, pneumonia. A billion market.

apooroldinvestor

Did you read the Seeking Alpha article on IFRX? I dont have a membership.

apooroldinvestor

Wow! I had IFRX a couple months ago but held it for a week and got rid of it. Big dummy! I might have to throw some in on Monday!

ColdMeeting2595

IFRX Simply put, Inflarax has a lot of studies in the final phase, where one alone has the potential to increase the price by 400% at once: Corona, cancer, pneumonia. A billion market.

VisualMod

I am a bot. You submitted a picture of a banned ticker, IFRX. This check will fire if you included unnecessary pictures that have bad phrases or a bad crop with news about cryptocoins, for example. Repost with the useless pictures omitted if you did that. Yell at /u/zjz if it's above 1.5 billion-ish market cap and not related to crypto/pennies/OTC.

ColdMeeting2595

IFRX Simply put, Inflarax has a lot of studies in the final phase, where one alone has the potential to increase the price by 400% at once: Corona, cancer, pneumonia. A billion market.

ColdMeeting2595

I have 20 k Invest IFRX.

ColdMeeting2595

IFRX ist The Germany BIOPHARMA Newcomer

apooroldinvestor

Seeking Alpha had an article in IFRX. I'm not a member. By the way is Seeking Alpha worth it?

noBinding

IFRX has great potential. Their drug is called vilobelimab. The stock comes in from $ 50 in 2019. There has been good news lately. These were above all the funding for the use against Covid by the German government and the prospect of the phase 3 study against HS (hidradenitis suppurativa). There will also be more news about PG (Pyoderma gangrenosum) in 2022. The balance sheet is excellent, a lot of cash. Unfortunately, only the CEO is a bore.

ColdMeeting2595

Inflarex IFRX has several published in the first quarter of 2022. where a single dan course will easily increase over 400%

ColdMeeting2595

IFRX Germany Biopharma Vilobelimab is not a Covid drug !!! It fights sepsis caused by Covid, and sepsis existed before Covid ... and will last long after Covid. Sepsis is one of the most common and cost-intensive diseases in the inpatient area. [1] The World Health Organization (WHO) declared the disease to be one of the leading priorities in the health systems of the member states in 2017 in order to improve the prevention, diagnosis, therapy, recording and follow-up care of sepsis patients. Here's a billion dollar market if not so billiards market. And Inflarex is on the verge of being the best drug with the fewest side effects. Just a few days!

ColdMeeting2595

IFRX Germany Biopharma Vilobelimab is not a Covid drug !!! It fights sepsis caused by Covid, and sepsis existed before Covid ... and will last long after Covid. Sepsis is one of the most common and cost-intensive diseases in the inpatient area. [1] The World Health Organization (WHO) declared the disease to be one of the leading priorities in the health systems of the member states in 2017 in order to improve the prevention, diagnosis, therapy, recording and follow-up care of sepsis patients. Here's a billion dollar market if not so billiards market. And Inflarex is on the verge of being the best drug with the fewest side effects. Just a few days!

ColdMeeting2595

IFRX Germany Biopharma Vilobelimab is not a Covid drug !!! It fights sepsis caused by Covid, and sepsis existed before Covid ... and will last long after Covid. Sepsis is one of the most common and cost-intensive diseases in the inpatient area. [1] The World Health Organization (WHO) declared the disease to be one of the leading priorities in the health systems of the member states in 2017 in order to improve the prevention, diagnosis, therapy, recording and follow-up care of sepsis patients. Here's a billion dollar market if not so billiards market. And Inflarex is on the verge of being the best drug with the fewest side effects. Just a few days!

ColdMeeting2595

IFRX Germany Biopharma Vilobelimab is not a Covid drug !!! It fights sepsis caused by Covid, and sepsis existed before Covid ... and will last long after Covid. Sepsis is one of the most common and cost-intensive diseases in the inpatient area. [1] The World Health Organization (WHO) declared the disease to be one of the leading priorities in the health systems of the member states in 2017 in order to improve the prevention, diagnosis, therapy, recording and follow-up care of sepsis patients. Here's a billion dollar market if not so billiards market. And Inflarex is on the verge of being the best drug with the fewest side effects. Just a few days!

VisualMod

I am a bot from /r/wallstreetbets. You submitted one or more banned tickers: IFRX. Message /u/zjz if they're above 1.5 billion-ish market cap and not related to crypto/pennies/OTC.

Full_Computer_1289

$IFRX It does not help just sitting and waiting and throwing shares onto a greedy throat of a shortseller. inflaRx is a German premium biotech company. If you buy their shares, hold them! If shortsellers attack IFRX again, hold them! …better: buy, buy, buy and roast the shortseller. Give him a lesson he never will forget So let us stand together!! $IFRX do not miss this chance. Every moment news can come and this will run up very fast! Do not let the shortseller play around here. once this is successful it can save millions of lives.. buy and hold and you will not regret it!

VisualMod

I am a bot from /r/wallstreetbets. You submitted one or more banned tickers: IFRX. Message /u/zjz if they're above 1.5 billion-ish market cap and not related to crypto/pennies/OTC.

VisualMod

I am a bot from /r/wallstreetbets. You submitted one or more banned tickers: IFRX. Message /u/zjz if they're above 1.5 billion-ish market cap and not related to crypto/pennies/OTC.

VisualMod

I am a bot from /r/wallstreetbets. You submitted one or more banned tickers: IFRX. Message /u/zjz if they're above 1.5 billion-ish market cap and not related to crypto/pennies/OTC.

throwawaymyalias

There is a small sleeper biotech stock out there that may prove promising: $IFRX. IFRX has Phase 3 study results coming out in 2022 Q1 on their drug Vilobelimab for Severe Covid. [https://www.inflarx.de/Home/Investors/Press-Releases/10-2021-InflaRx-Completes-Enrollment-of-Vilobelimab-Phase-III-Study-in-Severe-COVID-19.html](https://www.inflarx.de/Home/Investors/Press-Releases/10-2021-InflaRx-Completes-Enrollment-of-Vilobelimab-Phase-III-Study-in-Severe-COVID-19.html) With Omicron (which is being reported as severe) now in the news, IFRX may be setting for a Moon launch if Volibelimab is successful. (Which to date it has been.) Additionally, IFRX has a number of other study results coming out soon, which may further support a higher stock price. [https://www.inflarx.de/Home/Research---Development/Pipeline.html](https://www.inflarx.de/Home/Research---Development/Pipeline.html) IFRX has a market of $224M, and currently trades at $5.08. If you look at IFRX's all-time chart you'll see IFRX traded as high as the mid-$40s in 2019. A study result came out back then that decimated the stock, however, and IFRX has yet to recover. Oh, and of note: last month the German government provided IFRX a USD $50M grant, and the company currently has around USD $135M in cash and equivalents. So with or without COVID, I sense IFRX will soon be trading much higher than $5.00 due to many potential catalysts on the near horizon. Which is why I'm long 40,000 IFRX at an average price of $2.65. I've been holding for months, am already up big, but I'm not selling because I feel quite confident that we could see IFRX once again trading in the $20s, $30s or $40s if the news remains positive and big money decides to jump in.

timee_bot

View in your timezone: [November 15, at 4:30 pm EST][0] [0]: https://timee.io/20211115T2130?tl=Biotech%20Penny%20Stocks%20To%20Watch%20This%20Week%20w%2F%20Events%20-%20%24CBAY%20%24PHAS%20%24IFRX%20%24SEEL%20%26amp%3B%206%20More

Flyingninjavolt

IFRX

throwawaymyalias

​ First off, long time lurker. Still barely understand a fraction of what I read here, but I keep coming back. So... I own 40,000 IFRX at an average price of $2.60. (Started buying in August.) IFRX is now approaching $5.00, so I'm up nearly $100k. Based on my research, I believe IFRX has the potential to trade much higher by the end of this year/early next year. (Guesstimate: mid-teens.) So based on the above, what specific options strategy should I deploy towards at minimum locking in as much of my current gain as possible? I'm thinking covered calls, as I wouldn't care if, for example, IFRX were to get called away in the mid-teens and it subsequently traded higher. (Pfffttt... I made money, so I'm happy.) Additionally, I don't care if IFRX drops back down, as I'll still be fine holding the stock long-term. Again, my objective right now is to bank as much of my current gain as possible while still owning the stock. And finally, my prior options experience has simply been buying/selling puts and calls. So please no green eyed iron condor double penetration golden triangle two-step shuffle plays. In other words, keep it simply because I'm a simpleton.

Worth_It_Test

Data I have access to says 99% borrowing rate for shorting IFRX. Not surprised at all given the price action and volume on 10/28.

apooroldinvestor

I'm in with $440 on IFRX. Don't know if you've heard of them.

Equivalent-Fun9991

This German Corona Medezin company still seems to be somewhat unknown. Let our friends from the Wall Street Boys raise awareness on FB and Reddit. Where it deserves. $ 16 new target price. $ 50 million from the federal government to support rapid approval of the corona drug. It couldn't be any better. Warning, there are only 36 million shares in circulation. Many of them in firm hands. #IFRX

Equivalent-Fun9991

#IFRX Let's play inflarx NL0012661870. Only 27 million shares outstanding. Over 130 million in the bank. New Covid drug soon to be approved. Just received an additional 50 million dollars in funding from the German government. Look at the chart and come to Stocktwits. New target price of 16 dollars

apooroldinvestor

IFRX? Anyone else in on this one? I bought in with $400 at $3.30.

SufficientAd6587

IFRX as well

apooroldinvestor

IFRX just added 100 shares! Anyone else?

fifty2weekhi

Which tickers were you referring to? Not a bad day, especially with IFRX in the mix.

Spacevietnamees

I went for IFRX today.

nevergonnagiveuup17

IFRX

Equivalent-Fun9991

Kursziel vom Analysten wurde gestern auf 14 $ und strong buy hochgestuft und dazu das hier Positive Daten zu vilobelimab IFRX positive data from Phase IIa of vilobelimab On October 27, 2021, InflaRx N.V. (IFRX), announced positive data from the third cohort of patients in the Phase IIa open-label study with vilobelimab in Pyoderma Gangraenosum (PG). [url]https://marketglobalist.com/2021/10/28/here-is-why-inflarx-n-v-ifrx-stock-surged-in-the-after-hours-on-wednesday/

mistershiftstick

Keep watch on $GRTX and $IFRX tomorrow but be very careful. These popped after hours and could continue the momentum. Other tickers to keep an eye out for... AHT (should continue with its momentum), IRNT, MKD, PTE, SDC ​ Keep an eye on Energy stocks, in particular solar power. ​ Also CRTX (Cortexyme) failed their clinical trial for Alzhimers drug. While some want to run away from this, some would see it as a great opportunity. Just putting it out there. I am still in METX btw, I have a great average and am looking to stay longer in this bad boy. ​ Good luck boys and girls.

Cire_NojH

$IFRX is up premarket on news of grant for development of vilobelimab for the treatment of severely ill, mechanically ventilated COVID-19 patients.

rad-topher

Anyone else looking at IFRX? Seems like a similar situation to CCXI which pumped 100% a few days ago

throwawaymyalias

I've been holding DVAX shares since May, so today is a really nice change. drug for severe Covid induced pneumonia. At $2.75, IFRX is currently trading pennies above its all-time low and a whopping $50+ off its all-time (2019) high. So if the results are good (which to-date they have been), IFRX has a LOT or upside. I'm long both stock as well as NOV and JAN calls.

throwawaymyalias

IFRX. Go ahead and laugh - you'll see...!

VisualMod

I am a bot. You submitted a picture of a banned ticker, IFRX. This check will fire if you included unnecessary pictures that have bad phrases or a bad crop with news about cryptocoins, for example. Repost with the useless pictures omitted if you did that. Yell at /u/zjz if it's above 1.5 billion-ish market cap and not related to crypto/pennies/OTC/SPACs.

VisualMod

I am a bot. You submitted a picture of a banned ticker, IFRX. This check will fire if you included unnecessary pictures that have bad phrases or a bad crop with news about cryptocoins, for example. Repost with the useless pictures omitted if you did that. Yell at /u/zjz if it's above 1.25 billion-ish market cap and not related to crypto/pennies/OTC/SPACs.

fantusdk

IFRX - german medicine company. Trading at cash level at the moment and low Market cap around 150 million dollars. Could easily be a 5-10 bagger this year. See more on www.inflarx.de

Qknowswhatsup

Sorry IFRX

GoattSteve

Anyone bullish on $IFRX ? I've been doing some research and it has high potential but I wanna hear from the homies.